Preoperative Oral Hydration in the Ambulatory Arthroplasty Population
Launched by HOSPITAL FOR SPECIAL SURGERY, NEW YORK · Aug 25, 2022
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether drinking a special carbohydrate drink before surgery can help patients have shorter hospital stays after undergoing joint replacement surgeries, like total knee or hip arthroplasty. The goal is to see if this drink can help patients recover quickly enough to go home on the same day of their surgery, which is referred to as same-day discharge.
To participate, individuals need to be scheduled for one of these surgeries and agree to go home the same day. They should also have someone responsible who can be with them overnight after the surgery. However, not everyone can join; for example, those with certain medical conditions like diabetes or chronic kidney disease, or those who are pregnant, will not be eligible. If you decide to take part in this study, you will be asked to drink the carbohydrate drink before your surgery and then monitored to see how it affects your recovery. This trial is currently looking for participants, so it's a chance to contribute to important research that could improve recovery experiences for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Candidates for ambulatory total knee arthroplasty
- • Candidates for ambulatory total hip arthroplasty
- • Candidates for ambulatory revision knee arthroplasty (liner exchange only)
- • Candidates for ambulatory revision hip arthroplasty (liner exchange only)
- • Case scheduled before noon (12 pm)
- • Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge
- Exclusion Criteria:
- • BMI less than 18.5 or greater than 37.0
- • Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb.
- • Pregnant women
- • Patients scheduled as ambulatory due to insurance mandates
- • Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and glomerular filtration rate \< 60ml/min.
About Hospital For Special Surgery, New York
The Hospital for Special Surgery (HSS) in New York is a world-renowned institution specializing in orthopedic surgery, rheumatology, and rehabilitation. Recognized for its commitment to advancing medical research and improving patient outcomes, HSS serves as a leading clinical trial sponsor, facilitating innovative studies that explore cutting-edge treatments and therapies. With a team of expert clinicians and researchers, HSS aims to enhance clinical practices through rigorous scientific inquiry, ultimately contributing to the advancement of musculoskeletal health and patient care on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Jose A Rodriguez, MD
Principal Investigator
Hospital for Special Surgery, New York
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials